Literature DB >> 17264468

Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects.

Alev E Altinova1, Fusun Toruner, Neslihan Bukan, Demet Gokalp Yasar, Mujde Akturk, Nuri Cakir, Metin Arslan.   

Abstract

The purpose of this study was to investigate plasma adiponectin concentration and its relation with metabolic parameters in overweight and normal weight subjects. The study was carried out in 46 overweight subjects (20 male, 26 female; mean age 39.4 +/- 10.2 years) and 48 (19 male, 29 female; mean age 36.1 +/- 10.6 years) sex- and age-matched normal weight subjects. Anthropometric measurements were recorded and adiponectin, glucose, insulin, lipid profile, total homocysteine (tHcy) and fibrinogen levels were measured. The insulin resistance index was assessed by homeostasis model assessment for insulin resistance (HOMA-IR). Plasma mean adiponectin concentrations of the overweight subjects were significantly lower than those of normal weight subjects (15.0 +/- 4.2 vs 17.3 +/- 5.6 ng/ml) (P<0.05). In overweight subjects, adiponectin levels negatively correlated with body weight (r = -0.35, P<0.001), body mass index (BMI) (r = -0.28, P<0.006), systolic blood pressure (r = -0.21, P<0.04), fasting insulin (r = -0.19, P<0.01) and HOMA-IR (r = -0.20, P<0.01) and positively with high-density lipoprotein cholesterol (HDL-C) (r = 0.27, P<0.009). Overweight subjects with low HDL-C levels had significantly decreased plasma adiponectin levels compared to those with high HDL-C levels (P<0.05). Multiple regression analysis revealed that BMI, HOMA-IR and HDL-C explained 12%, 20% and 15% variance of the adiponectin concentrations. These findings may suggest that circulating adiponectin is associated with insulin resistance and HDL-C levels independent from BMI in overweight subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264468     DOI: 10.1507/endocrj.k06-021

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  15 in total

1.  Omental gene expression of adiponectin correlates with degree of insulin sensitivity before and after gastric bypass surgery.

Authors:  Jiegen Chen; Anna Spagnoli; Alfonso Torquati
Journal:  Obes Surg       Date:  2012-03       Impact factor: 4.129

2.  Genetic effects of adiponectin single nucleotide polymorphisms on the clustering of metabolic risk factors in young Korean adults.

Authors:  Ji-Young Lee; Jin-Kyung Cho; Hye-Ryun Hong; Young-Yoon Jin; Hyun-Sik Kang
Journal:  Eur J Appl Physiol       Date:  2011-06-01       Impact factor: 3.078

Review 3.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

4.  Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Authors:  Bronwen Martin; Wayne Chadwick; Wei-na Cong; Nick Pantaleo; Caitlin M Daimon; Erin J Golden; Kevin G Becker; William H Wood; Olga D Carlson; Josephine M Egan; Stuart Maudsley
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

5.  Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.

Authors:  Joseph Tam; Grzegorz Godlewski; Brian J Earley; Liang Zhou; Tony Jourdan; Gergö Szanda; Resat Cinar; George Kunos
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-31       Impact factor: 4.310

6.  Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).

Authors:  Krasimira Aleksandrova; Mazda Jenab; H Bas Bueno-de-Mesquita; Veronika Fedirko; Rudolf Kaaks; Annekatrin Lukanova; Fränzel J B van Duijnhoven; Eugene Jansen; Sabina Rinaldi; Isabelle Romieu; Pietro Ferrari; Neil Murphy; Marc J Gunter; Elio Riboli; Sabine Westhpal; Kim Overvad; Anne Tjønneland; Jytte Halkjær; Marie-Christine Boutron-Ruault; Laure Dossus; Antoine Racine; Antonia Trichopoulou; Christina Bamia; Philippos Orfanos; Claudia Agnoli; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Petra H Peeters; Eric J Duell; Esther Molina-Montes; J Ramón Quirós; Miren Dorronsoro; Maria-Dolores Chirlaque; Aurelio Barricarte; Ingrid Ljuslinder; Richard Palmqvist; Ruth C Travis; Kay-Tee Khaw; Nicholas Wareham; Tobias Pischon; Heiner Boeing
Journal:  Eur J Epidemiol       Date:  2014-05-04       Impact factor: 8.082

7.  Epidemiologic evidence on serum adiponectin level and lipid profile.

Authors:  Vajihe Izadi; Elaheh Farabad; Leila Azadbakht
Journal:  Int J Prev Med       Date:  2013-02

8.  Adiponectin levels and expression of adiponectin receptors in isolated monocytes from overweight patients with coronary artery disease.

Authors:  Anastasios Kollias; Panayoula C Tsiotra; Ignatios Ikonomidis; Eirini Maratou; Panayota Mitrou; Erifyli Kyriazi; Eleni Boutati; John Lekakis; Theofanis Economopoulos; Dimitrios T Kremastinos; George Dimitriadis; Sotirios A Raptis
Journal:  Cardiovasc Diabetol       Date:  2011-02-01       Impact factor: 9.951

9.  Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.

Authors:  Bronwen Martin; Erin Golden; Olga D Carlson; Paul Pistell; Jie Zhou; Wook Kim; Brittany P Frank; Sam Thomas; Wayne A Chadwick; Nigel H Greig; Gillian P Bates; Kirupa Sathasivam; Michel Bernier; Stuart Maudsley; Mark P Mattson; Josephine M Egan
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

10.  Effect of a High Protein Weight Loss Diet on Weight, High-Sensitivity C-Reactive Protein, and Cardiovascular Risk among Overweight and Obese Women: A Parallel Clinical Trial.

Authors:  Leila Azadbakht; Vajihe Izadi; Pamela J Surkan; Ahmad Esmaillzadeh
Journal:  Int J Endocrinol       Date:  2013-08-06       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.